Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Hjørring – page 2

19 clinical trials in Hjørring, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Hjørring at a glance
19
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

19 trials in Hjørring

Open in trial search

Myocardial infarction

Not recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bisoprolol Fumarate
  • Sponsor:Frederiksberg Hospital

Cardiac failure chronic

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Isosorbide Dinitrate

Type IIa hyperlipidaemia

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Lichen sclerosus

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alanyl Glutamine
  • Sponsor:Mc2 Therapeutics Limited

Cardiac arrest

Not recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Midtjylland

Heart failure with reduced ejection fraction

Not recruiting
Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Hjørring

What the registry says about research in the country

01 Hjørring
Cardiovascular Diseases
Clinical trials in cardiovascular diseases are a major focus in Hjørring, with studies centered on prevention and treatment of heart-related conditions. The research is aimed at improving outcomes for patients at risk of serious events and reducing the burden of long-term heart disease. Testing new approaches for heart failure, including reduced ejection fraction and obesity-related forms Studying prevention of atherosclerotic cardiovascular disease, myocardial infarction, and stroke-related events Evaluating therapies for atrial fibrillation, NSTEMI, and recurrent cardiac complications Assessing treatments to lower cardiovascular death and hospitalizations These trials support better risk reduction, symptom control, and long-term management for people with high cardiovascular risk.
Critical Care and Emergency Conditions
Several trials address acute and intensive care needs, especially for patients with life-threatening illness. The main goal is to improve survival and recovery in severe hospital-based conditions. Research on sepsis and septic shock in critically ill adults Studies for in-hospital cardiac arrest and return of spontaneous circulation Evaluating fluid management in fluid overload among ICU patients Testing whether common treatments can improve outcomes in emergency care These studies aim to guide faster, more effective decisions in urgent and high-risk clinical settings.
Infectious Diseases and Vaccines
Research in infectious diseases covers both prevention and treatment, with trials involving bacterial infections and viral illnesses. The work includes vaccine studies and therapies for serious infections. Vaccine research for RSV prevention, meningococcal infection, and varicella Evaluating immune responses in healthy infants and children Comparing antibiotics for sepsis in critically ill adults Supporting better protection against preventable viral and bacterial diseases These trials focus on reducing infection risk and improving public health through stronger prevention strategies.
Immune-Mediated and Skin Conditions
Some studies in the city focus on immune system processes and related skin disorders. This includes trials designed to ease chronic symptoms and improve quality of life for people with persistent inflammatory conditions. Investigating treatment options for vulvar lichen sclerosus Exploring therapies that may reduce inflammation and discomfort Assessing whether topical treatment can improve patient-reported outcomes These trials are aimed at better symptom control and more effective care for chronic skin and mucosal disease.
Prevention of Thrombotic and Cerebrovascular Events
Another important research area is the prevention of blood-clot-related complications, especially in people with atrial fibrillation or established vascular disease. The emphasis is on lowering the risk of stroke, heart attack, and other major events. Testing strategies to prevent stroke and systemic embolism in atrial fibrillation Studying ways to reduce major adverse cardiovascular events Evaluating treatment options for patients with ASCVD and high cholesterol-related risk Looking at the balance between benefit and bleeding risk These studies may help refine long-term prevention for patients living with ongoing cardiovascular risk.
Metabolic and Supportive Heart Failure Research
Trials also examine broader contributors to heart disease, including metabolic and supportive treatments for people with chronic heart failure. This research aims to improve everyday outcomes and reduce worsening illness. Studying treatments for chronic heart failure with reduced ejection fraction Exploring options for patients with HFpEF or HFmrEF and obesity Assessing therapies intended to reduce hospitalization and urgent care use Supporting better management of complex, long-term heart failure In Denmark, this line of research reflects a practical effort to improve daily care for patients living with advanced heart disease.
Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.